Atlas Trials

Relapsed/Refractory Follicular Lymphoma

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed/Refractory Follicular Lymphoma

RecordFirmDate
Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for Relapsed or Refractory Follicular Lymphoma (NCT05338879)Regeneron Pharmaceuticals2022-06-22
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma (NCT05100862)BeOne Medicines2022-03-10
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma. (NCT04224493)Epizyme, Inc.2020-06-11
A Study of TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL) (NCT04324879)Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2020-05-20
Towards Personalized Medicine for Refractory/Relapsed Follicular Lymphoma Patients: the Cantera/Lupiae Registry (NCT04587388)European Hematology Association - Lymphoma Group2019-05-22
Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma (NCT03939026)Allogene Therapeutics2019-05-01

Track Relapsed/Refractory Follicular Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.